Come up with a name for your new list and we'll add to it:
Alpine Immune Sciences - GSNOR Unit raised a round of funding on July 20, 2018. Investors include
Laurel Venture Capital.
Alpine Immune Sciences uses proprietary variant immunoglobulin domain (vIgD) platform technology – designed to interact with multiple targets simultaneously in the immune synapse using a single mole…